CRM And Lifecycle Lead

About Eucalyptus

We're on a mission to make good health last a lifetime. More than 1 billion people live with obesity worldwide, driving preventable chronic conditions. We're here to build better long-term care.

Eucalyptus is now part of Hims & Hers, the global leader in personalised health and wellness.

Euc is the company behind Juniper, one of the world's largest weight-management programs combining GLP-1 medication with personalised nutrition, movement support, and clinician-led care from prescribers, nurses, health coaches, pharmacists, and dietitians. Our published clinical research shows that our combined clinical and behavioural approach helps patients lose significantly more weight during their treatment with Juniper by four times.

Our Growth Story:

• Supporting patients living with obesity across our 5 markets
• Received selective NICE endorsement to provide services to the NHS
• Tailored our offering to thousands of patients in Australia, the UK, Germany, Japan and Canada.

How we think about marketing

At Euc, marketing is about capturing attention and turning it into real growth.

We're not here to chase perfect open rates or vanity metrics. We're here to grow the business by reaching people, earning their trust, and helping them get real outcomes from the treatment they've started.

We move fast. Really fast. Because when ideas ship quicker, we learn quicker, make bolder bets, and don't waste months on "safe" programs that never move the needle.

Here's how we think:

• Creative wins. We don't have exclusive access to channels, so great storytelling is how we stand out and earn attention
• Speed matters. Fast tests beat perfect plans. We ship early, learn fast, and move on
• Lifecycle is a growth lever, not a cost centre. The work after the sale (activation, adherence, retention) compounds, and we treat it that way
• Data is a compass. We ask why, not just what. Trends are more useful than daily swings. Insight plus action equals impact
• We focus on outcomes, not channels. Email, SMS, WhatsApp, push, in-app, we use whatever moves the patient forward in that market. No channel loyalty. Just growth

What's next?

We're entering one of our most ambitious chapters yet. Over the next 12 months we're scaling our existing international markets (Germany, Canada, Japan) and launching Juniper into new ones, with the goal of three more markets live by the end of the year.

To get there, we're centralising growth as a function across the international team, building the central engines that let every market scale faster than it could alone. Lifecycle is one of those engines.